You are here: Home / About the Faculty / Faculty Staff / Academic Staff

Dr Parisa Aslani

Senior Lecturer, Pharmacy Practice

Qualifications

BPharm(Hons) MSc PhD G Cert Ed Stud (Higher Ed), MPS MRPharmS

Contact Details

University of Sydney
Phone: + 61 2 9036 6541
Fax: + 61 2 9351 4391
Email:
Room S241
Pharmacy Building A15
The University of Sydney
NSW 2006 Australia

Background

Dr Aslani’s research addresses areas of fundamental significance: the design of Consumer Medicine Information (CMI); and, issues that impact the Quality Use of Medicines (QUM). Dr Aslani’s profound long-term goal is to determine how consumers evaluate medicine information, enabling the profession to enhance patient access to and understanding of medicines. This is a critical step towards promoting adherence, concordance and compliance within varied Australian communities. As well as being an active researcher – where research teams of which she is a member have received $2.68 million in grants - Dr Aslani has supervised 5 doctoral, 4 masters, and 14 honours students.

Research Interests

Dr Aslani’s area of research focuses on Consumer Medicine Information (CMI) where she aims to optimise patient care and quality use of medicines through the use of effective medicine information. Measuring the effectiveness of medicine information format and delivery is a critical step towards promoting adherence and compliance. Dr Aslani’s research also focuses on adherence to therapy, in particular in the area of cardiovascular medicines. Her research aims to improve patient adherence through educating patients and healthcare professionals. The educational programs foster a concordant approach to patient care. In the “Consumer Medicine Information Effectiveness” project, Dr Aslani leads a team of national and international experts who aim to develop and evaluate viable alternative CMI formats to ensure optimal effectiveness and best practice delivery in community pharmacy practice.

Research work developed in the area of CMI by Dr Aslani has led to the implementation and dissemination of a national training program through the Pharmaceutical Society of Australia on the use of Consumer Medicine Information in community pharmacies. This training program has also been integrated in the undergraduate and postgraduate curricula at the Faculty of Pharmacy. Dr Aslani also leads a team working with the Heart Foundation to assist targeted healthcare professional organisations to achieve an understanding of the issues related to adherence, how to overcome them and the importance of adherence in achieving health outcomes. A key to success in the prevention and management of chronic diseases such as cardiovascular disease is ongoing adherence and persistence to prescribed therapy, which applies equally to the management of symptomless risk factors such as hypertension and dyslipidaemia, as well as cardiovascular complications such as ischaemic heart disease and heart failure.

Back to Top

Higher Degree Research Candidates

  • El Samman, Fadwa
    Master of Philosophy
    "Medicine and disease information needs of older Arabic-speaking Australians"
    Start: February 2007
    Submit: July 2009
    Secondary Supervisors: McLachlan & Chaar
  • Ellitt, Glena R.
    Doctor of Philosophy, Part-time
    "Multidisciplinary continuity of patient care"
    Start: July 2003
    Submit: July 2010
    Primary Supervisor: Chen
    Secondary Supervisor: Brien & Aslani
  • Hamrosi, Kim K.
    Doctor of Philosophy
    "The evaluation, development and testing of alternative forms of written medicine information for customers"
    Start: February 2009
    Submit: February 2013
    Secondary Supervisor: Raynor

Select Journal Articles

  1. Du Pasquier S and Aslani P (2008) Concordance-based adherence support service delivery in community pharmacy: consumer perspectives Pharmacy World and Science- 30: pp846-853.
  2. de Almeida Neto A, Aslani P. (2008) Medicines concordance in clinical practice. British Journal of Clinical Pharmacology- 66(4): pp453-454.
  3. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P (2008) Practice change in community pharmacy: quantification of facilitators. Annals of Pharmacotherapy- 42 pp861-8.
  4. Mai A, Aslani P (2007) Impact of Vietnamese written medicine information on consumers’ knowledge and satisfaction. British Journal of Clinical Pharmacology 64(4): pp527-535.
  5. Aslani P (2007) Consumer Medicine Information Conundrums. Australian Prescriber- 30(5): pp122-124.
  6. Koo MM, Krass I, Aslani P (2007) Evaluation of written medicine information: international validation of the Consumer Information Rating Form Annals of Pharmacotherapy- 41(6): pp951-956.
  7. Aslani P, Benrimoj SI and Krass I. (2007) Development and Evaluation of a training program to foster the use of written drug information in community pharmacies- Part 2- Evaluation. Pharmacy Education- 7(2) pp141-149.
  8. Raynor DK, Svarstad B, Knapp P, Aslani P, Rogers B, Koo M, Krass I, Silcock J. (2007) Consumer Medicines Information in the United States, Europe and Australia - a comparative evaluation. Journal of the American Pharmacists Association 47 pp717-724.
  9. Bell JS, Airaksinen MS, Lyles A, Chen TF, Aslani P (2007) Concordance is not synonymous with compliance or adherence. British Journal of Clinical Pharmacology 64(5)pp710-711.
  10. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P (2006) Implementing cognitive services in community pharmacy: a review of facilitators of practice change International Journal of Pharmacy Practice- 14 pp163-170.
Back to Top